Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 54 (6) , 1021-1027
- https://doi.org/10.1016/s0015-0282(16)53999-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Gestrinone versus danazol in the treatment of endometriosisPublished by Elsevier ,2016
- Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosisFertility and Sterility, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile womenFertility and Sterility, 1982
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1982
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonistFertility and Sterility, 1982
- Clinical Studies with an Antigonadotropin-DanazolFertility and Sterility, 1971
- The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian HormonesFertility and Sterility, 1959